175 related articles for article (PubMed ID: 29052216)
1. Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16-29 years.
Varanasi LC; Subasinghe A; Jayasinghe YL; Callegari ET; Garland SM; Gorelik A; Wark JD
Aust N Z J Obstet Gynaecol; 2018 Apr; 58(2):222-233. PubMed ID: 29052216
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study.
Joham AE; Teede HJ; Ranasinha S; Zoungas S; Boyle J
J Womens Health (Larchmt); 2015 Apr; 24(4):299-307. PubMed ID: 25654626
[TBL] [Abstract][Full Text] [Related]
3. Impact of a diagnosis of polycystic ovary syndrome on diet, physical activity and contraceptive use in young women: findings from the Australian Longitudinal Study of Women's Health.
Copp T; Cvejic E; McCaffery K; Hersch J; Doust J; Mol BW; Dokras A; Mishra G; Jansen J
Hum Reprod; 2020 Feb; 35(2):394-403. PubMed ID: 32003425
[TBL] [Abstract][Full Text] [Related]
4. Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis.
Rowlands IJ; Teede H; Lucke J; Dobson AJ; Mishra GD
Hum Reprod; 2016 Sep; 31(9):2072-81. PubMed ID: 27412249
[TBL] [Abstract][Full Text] [Related]
5. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
8. [Polycystic ovary syndrome: is there a rise in the prevalence?].
Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care.
Tannus S; Tan J; Son WY; Dahan MH
Arch Gynecol Obstet; 2018 Apr; 297(4):1037-1042. PubMed ID: 29289990
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.
Teede HJ; Joham AE; Paul E; Moran LJ; Loxton D; Jolley D; Lombard C
Obesity (Silver Spring); 2013 Aug; 21(8):1526-32. PubMed ID: 23818329
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
[TBL] [Abstract][Full Text] [Related]
13. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966.
West S; Vähäsarja M; Bloigu A; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Corbett S; Vääräsmäki M; Morin-Papunen L
Hum Reprod; 2014 Mar; 29(3):628-33. PubMed ID: 24324025
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
Joham AE; Boyle JA; Zoungas S; Teede HJ
Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study.
Ganie MA; Rashid A; Sahu D; Nisar S; Wani IA; Khan J
Int J Gynaecol Obstet; 2020 May; 149(2):231-236. PubMed ID: 32080845
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: An Australian population-based study.
Tay CT; Teede HJ; Loxton D; Kulkarni J; Joham AE
Psychoneuroendocrinology; 2020 Jun; 116():104678. PubMed ID: 32361187
[TBL] [Abstract][Full Text] [Related]
17. A survey of the use of complementary medicine by a self-selected community group of Australian women with polycystic ovary syndrome.
Arentz S; Smith CA; Abbott JA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():472. PubMed ID: 25481654
[TBL] [Abstract][Full Text] [Related]
18. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
20. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
